$2.32 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 59 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 32.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Buy | BIOGEN IDEC INC | $152,248,000 | +121.0% | 544,575 | +90.3% | 6.57% | +98.1% |
| GILD | Sell | GILEAD SCIENCES INC | $145,812,000 | -14.0% | 1,941,573 | -28.0% | 6.29% | -22.9% |
| AMGN | Sell | AMGEN INC | $144,041,000 | +0.3% | 1,262,633 | -1.6% | 6.21% | -10.1% |
| CELG | Sell | CELGENE CORP | $119,365,000 | -3.0% | 706,436 | -11.5% | 5.15% | -13.1% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $91,549,000 | -2.3% | 1,232,158 | -0.3% | 3.95% | -12.4% |
| REGN | Buy | REGENERON PHARMCTCLS | $75,966,000 | +38.7% | 276,000 | +57.7% | 3.28% | +24.4% |
| HALO | Buy | HALOZYME THERAPEUTIC | $70,473,000 | +45.5% | 4,701,362 | +7.2% | 3.04% | +30.4% |
| THRX | Buy | THERAVANCE INC | $70,344,000 | -11.4% | 1,973,188 | +1.5% | 3.03% | -20.6% |
| SHPG | Buy | SHIRE PLCsp adr | $66,231,000 | +34.2% | 468,759 | +13.9% | 2.86% | +20.3% |
| ALXN | Buy | ALEXION PHARM INC | $65,951,000 | +14.8% | 496,308 | +0.4% | 2.84% | +2.9% |
| AGN | Buy | ALLERGAN INC | $62,353,000 | +58.8% | 561,333 | +29.3% | 2.69% | +42.4% |
| INCY | Sell | INCYTE CORPORATION | $60,010,000 | -37.7% | 1,185,260 | -53.1% | 2.59% | -44.2% |
| MYL | Buy | MYLAN INC | $59,402,000 | +31.1% | 1,368,707 | +15.3% | 2.56% | +17.5% |
| IRWD | Buy | IRONWOOD PHARMACEUCL | $59,037,000 | +3.9% | 5,084,999 | +5.9% | 2.55% | -6.9% |
| TMO | Sell | THERMO FISHER SCI | $57,523,000 | -1.4% | 516,600 | -18.4% | 2.48% | -11.6% |
| MRK | Buy | MERCK & CO INC | $54,789,000 | +14.8% | 1,094,683 | +9.2% | 2.36% | +2.9% |
| CLDX | Buy | CELLDEX THERAPEUTICS | $53,932,000 | +61.2% | 2,227,688 | +135.9% | 2.33% | +44.5% |
| P103PS | Sell | NPS PHARMACEUTICALS | $53,887,000 | -18.7% | 1,774,919 | -14.8% | 2.32% | -27.1% |
| B108PS | New | ACTAVIS PLC | $51,601,000 | – | 307,150 | +100.0% | 2.22% | – |
| IMGN | Sell | IMMUNOGEN INC | $51,540,000 | -17.1% | 3,513,282 | -3.8% | 2.22% | -25.7% |
| PRGO | New | PERRIGO CO | $50,223,000 | – | 327,268 | +100.0% | 2.17% | – |
| BMRN | Sell | BIOMARIN PHARMAC INC | $50,216,000 | -3.6% | 713,806 | -1.1% | 2.17% | -13.6% |
| ISIS | Buy | ISIS PHARMACEUTICALS | $48,700,000 | +193.9% | 1,222,401 | +176.9% | 2.10% | +163.5% |
| GEVA | Buy | SYNAGEVA BIOPHARMA | $47,828,000 | +60.2% | 739,005 | +56.9% | 2.06% | +43.7% |
| OMED | Buy | ONCOMED PHARMACEUT | $36,015,000 | +122.0% | 1,220,006 | +15.2% | 1.55% | +99.1% |
| KERX | New | KERYX BIOPHARMACEUT | $35,728,000 | – | 2,758,950 | +100.0% | 1.54% | – |
| CLVS | Buy | CLOVIS ONCOLOGY | $28,472,000 | +9.9% | 472,400 | +10.8% | 1.23% | -1.5% |
| PTLA | Buy | PORTOLA PHARMACEUTIC | $25,797,000 | -0.3% | 1,001,814 | +3.6% | 1.11% | -10.6% |
| INSM | Buy | INSMED INC | $25,366,000 | +12.3% | 1,492,121 | +3.1% | 1.09% | +0.6% |
| ISRG | New | INTUITIVE SURGIC INC | $25,244,000 | – | 65,725 | +100.0% | 1.09% | – |
| BSX | Buy | BOSTON SCIENTIFIC | $25,261,000 | +44.9% | 2,101,605 | +41.5% | 1.09% | +29.8% |
| ABBV | New | ABBVIE INC | $24,962,000 | – | 472,672 | +100.0% | 1.08% | – |
| MDVN | Sell | MEDIVATION INC | $24,811,000 | -59.2% | 388,760 | -61.6% | 1.07% | -63.4% |
| F113PS | Buy | COVIDIEN PLC | $24,685,000 | +19.2% | 362,479 | +6.7% | 1.06% | +6.9% |
| TEVA | Buy | TEVA PHARMACEUTICALadr | $24,595,000 | +50.0% | 613,649 | +41.4% | 1.06% | +34.5% |
| MNKKQ | Buy | MALLINCKRODT PLC | $23,745,000 | +113.1% | 454,364 | +79.8% | 1.02% | +91.0% |
| ILMN | Sell | ILLUMINA INC | $23,300,000 | -17.7% | 210,689 | -39.9% | 1.00% | -26.3% |
| AKRXQ | Buy | AKORN INC | $21,850,000 | +50.6% | 887,482 | +20.4% | 0.94% | +35.0% |
| UTHR | New | UNITED THERAPEUTICS | $20,581,000 | – | 182,000 | +100.0% | 0.89% | – |
| ALGN | Sell | ALIGN TECH INC | $18,345,000 | +2.7% | 321,047 | -13.6% | 0.79% | -8.0% |
| RDY | Sell | DR REDDYS LABS LTDadr | $17,815,000 | +6.6% | 434,190 | -1.8% | 0.77% | -4.5% |
| PCYC | PHARMACYCLICS INC | $17,816,000 | -23.5% | 168,425 | 0.0% | 0.77% | -31.4% | |
| SGNT | Buy | SAGENT PHARMACEUTI | $17,505,000 | +52.1% | 689,729 | +22.2% | 0.76% | +36.3% |
| SGEN | Sell | SEATTLE GENETICS INC | $16,854,000 | -9.0% | 422,519 | -0.0% | 0.73% | -18.4% |
| MNTA | Buy | MOMENTA PHARMACEUTIC | $15,818,000 | +29.0% | 894,696 | +5.0% | 0.68% | +15.6% |
| HTWR | Buy | HEARTWARE INTL INC | $15,557,000 | +98.0% | 165,675 | +54.3% | 0.67% | +77.5% |
| TRNX | Buy | TORNIER N V | $10,773,000 | +29.2% | 573,321 | +32.9% | 0.46% | +16.0% |
| ARAY | Sell | ACCURAY INC | $7,555,000 | +9.3% | 868,386 | -7.3% | 0.33% | -1.8% |
| NXTM | Sell | NXSTAGE MEDICAL | $7,534,000 | -48.0% | 753,434 | -31.6% | 0.32% | -53.4% |
| DXCM | Sell | DEXCOM INC | $5,673,000 | +3.3% | 160,217 | -17.7% | 0.24% | -7.2% |
| HOLX | Sell | HOLOGIC INC | $5,352,000 | -31.2% | 239,485 | -36.4% | 0.23% | -38.2% |
| NVO | Buy | NOVO-NORDISK ASadr | $3,718,000 | +11.1% | 20,126 | +1.8% | 0.16% | -0.6% |
| RLYP | New | RELYPSA INC | $1,250,000 | – | 50,000 | +100.0% | 0.05% | – |
| NVS | Buy | NOVARTIS AGsp adr | $973,000 | +15.3% | 12,100 | +10.0% | 0.04% | +2.4% |
| PTCT | PTC THERAPEUTICS I | $976,000 | -20.9% | 57,519 | 0.0% | 0.04% | -28.8% | |
| KPTI | New | KARYOPHARM THERAPE | $802,000 | – | 35,000 | +100.0% | 0.04% | – |
| TNDM | New | TANDEM DIABETES CA | $515,000 | – | 20,000 | +100.0% | 0.02% | – |
| XLRN | New | ACCELERON PHARMA | $389,000 | – | 9,827 | +100.0% | 0.02% | – |
| WX | New | WUXI PHAR ADSsp adr | $230,000 | – | 6,000 | +100.0% | 0.01% | – |
| ACHN | Exit | ACHILLION PHARMA | $0 | – | -384,300 | -100.0% | -0.06% | – |
| EVAC | Exit | EDWARDS LIFESCIENCE | $0 | – | -196,669 | -100.0% | -0.66% | – |
| PFE | Exit | PFIZER INC | $0 | – | -690,676 | -100.0% | -0.95% | – |
| VPHM | Exit | VIROPHARMA INC | $0 | – | -556,024 | -100.0% | -1.05% | – |
| PRGO | Exit | PERRIGO CO | $0 | – | -231,185 | -100.0% | -1.37% | – |
| ACT | Exit | ACTAVIS INC | $0 | – | -202,650 | -100.0% | -1.40% | – |
| ARIA | Exit | ARIAD PHARMACEUTICAL | $0 | – | -3,008,541 | -100.0% | -2.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.